Bulletin
Investor Alert

New York Markets Open in:

CareDx Inc.

NAS: CDNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 21, 2019, 5:56 p.m.

/zigman2/quotes/200138382/composite

$

19.55

Change

0.00 0.00%

Volume

Volume 22,003

Quotes are delayed by 20 min

/zigman2/quotes/200138382/composite

Previous close

$ 19.24

$ 19.55

Change

+0.31 +1.61%

Day low

Day high

$18.75

$19.72

Open

52 week low

52 week high

$18.75

$41.27

Open

Company Description

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Valuation

P/E Current

-14.67

P/E Ratio (with extraordinary items)

-38.94

Price to Sales Ratio

11.70

Price to Book Ratio

10.85

Enterprise Value to EBITDA

-74.72

Enterprise Value to Sales

6.74

Total Debt to Enterprise Value

0.00

Efficiency

Revenue/Employee

331,468.00

Income Per Employee

-202,407.00

Receivables Turnover

12.01

Total Asset Turnover

0.69

Liquidity

Current Ratio

4.16

Quick Ratio

3.91

Cash Ratio

3.31

Profitability

Gross Margin

55.61

Operating Margin

-19.02

Pretax Margin

-62.97

Net Margin

-61.06

Return on Assets

-42.43

Return on Equity

-104.14

Return on Total Capital

-23.40

Return on Invested Capital

-86.28

Capital Structure

Total Debt to Total Equity

0.44

Total Debt to Total Capital

0.44

Total Debt to Total Assets

0.31

Long-Term Debt to Equity

0.26

Long-Term Debt to Total Capital

0.26

Officers and Executives

Name Age Officer Since Title
Dr. Reginald Seeto 46 2018 President & Chief Business Officer
Dr. Peter K. Maag 51 2012 Chief Executive Officer & Director
Mr. Paul Ciccolella - 2018 Senior Vice President-Global Operations
Mr. Michael Bell 50 2017 Chief Financial & Principal Accounting Officer
Dr. James P. Yee 66 2006 Chief Medical Officer & Executive Vice President

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/01/2019 George W. Bickerstaff
Director
541   Award at $0 per share. 0
10/01/2019 Michael D. Goldberg
Director
848   Award at $0 per share. 0
10/01/2019 Ralph D. Snyderman
Director
541   Award at $0 per share. 0
10/01/2019 Christine M. Cournoyer
Director
80   Award at $0 per share. 0
10/01/2019 Grace E. Colón
Director
270   Award at $0 per share. 0
09/01/2019 Christine M. Cournoyer
Director
6,573   Award at $0 per share. 0
08/06/2019 Peter K. Maag
Chief Executive Officer; Director
50,000   Award at $0 per share. 0
08/06/2019 Peter K. Maag
Chief Executive Officer; Director
50,000   Award at $0 per share. 0
08/06/2019 Michael Bell
Chief Financial Officer
5,000   Award at $0 per share. 0
08/06/2019 Reginald Seeto
See Remarks
5,000   Award at $0 per share. 0
08/06/2019 Sasha King
Chief Commercial Officer
2,500   Award at $0 per share. 0
08/06/2019 Peter K. Maag
Chief Executive Officer; Director
5,191   Disposition at $30.39 per share. 157,754
08/06/2019 Peter K. Maag
Chief Executive Officer; Director
25,303   Disposition at $29.56 per share. 747,956
08/06/2019 Peter K. Maag
Chief Executive Officer; Director
8,741   Disposition at $28.07 per share. 245,359
08/06/2019 Peter K. Maag
Chief Executive Officer; Director
10,765   Disposition at $27.01 per share. 290,762
07/11/2019 Fred E. Cohen
Director
5,255   Derivative/Non-derivative trans. at $5.02 per share. 26,380
07/11/2019 Fred E. Cohen
Director
5,255   Derivative/Non-derivative trans. at $5.85 per share. 30,741
07/11/2019 Fred E. Cohen
Director
5,255   Derivative/Non-derivative trans. at $10 per share. 52,550
07/01/2019 George W. Bickerstaff
Director
468   Award at $0 per share. 0
07/01/2019 Michael D. Goldberg
Director
734   Award at $0 per share. 0
07/01/2019 Ralph D. Snyderman
Director
312   Award at $0 per share. 0
07/01/2019 Grace E. Colón
Director
4,181   Award at $0 per share. 0
07/01/2019 Sasha King
Chief Commercial Officer
250   Derivative/Non-derivative trans. at $1 per share. 250
07/01/2019 James P. Yee
Chief Medical Officer
19,875   Derivative/Non-derivative trans. at $2.3 per share. 45,712
07/01/2019 Sasha King
Chief Commercial Officer
9,542   Disposition at $35.74 per share. 341,031
07/01/2019 James P. Yee
Chief Medical Officer
20,000   Disposition at $35.65 per share. 713,000
06/20/2019 Michael Bell
Chief Financial Officer
14,702   Disposition at $38.81 per share. 570,584
06/20/2019 Sasha King
Chief Commercial Officer
30,840   Disposition at $38.38 per share. 1,183,639
06/20/2019 Michael Bell
Chief Financial Officer
12,500   Derivative/Non-derivative trans. at $12.24 per share. 153,000
06/20/2019 Michael Bell
Chief Financial Officer
292   Derivative/Non-derivative trans. at $6.31 per share. 1,842
06/20/2019 Michael Bell
Chief Financial Officer
937   Derivative/Non-derivative trans. at $5.9 per share. 5,528
06/20/2019 Michael Bell
Chief Financial Officer
139   Derivative/Non-derivative trans. at $2.8 per share. 389
06/20/2019 Michael Bell
Chief Financial Officer
834   Derivative/Non-derivative trans. at $1 per share. 834
06/20/2019 Sasha King
Chief Commercial Officer
12,500   Derivative/Non-derivative trans. at $12.24 per share. 153,000
06/20/2019 Sasha King
Chief Commercial Officer
833   Derivative/Non-derivative trans. at $6.31 per share. 5,256
06/20/2019 Sasha King
Chief Commercial Officer
1,667   Derivative/Non-derivative trans. at $5.9 per share. 9,835
06/20/2019 Sasha King
Chief Commercial Officer
278   Derivative/Non-derivative trans. at $2.8 per share. 778
06/20/2019 Sasha King
Chief Commercial Officer
417   Derivative/Non-derivative trans. at $1.07 per share. 446
06/20/2019 Sasha King
Chief Commercial Officer
500   Derivative/Non-derivative trans. at $1 per share. 500
06/17/2019 George W. Bickerstaff
Director
2,613   Award at $0 per share. 0
06/17/2019 Michael D. Goldberg
Director
2,613   Award at $0 per share. 0
06/17/2019 Fred E. Cohen
Director
2,613   Award at $0 per share. 0
06/17/2019 Ralph D. Snyderman
Director
2,613   Award at $0 per share. 0
06/17/2019 William A. Hagstrom
Director
2,613   Award at $0 per share. 0
06/17/2019 James P. Yee
Chief Medical Officer
20,000   Derivative/Non-derivative trans. at $6.49 per share. 129,800
06/17/2019 James P. Yee
Chief Medical Officer
20,000   Disposition at $37.54 per share. 750,800
06/04/2019 William A. Hagstrom
Director
15,000   Disposition at $32.35 per share. 485,250
06/03/2019 Peter K. Maag
Chief Executive Officer; Director
18,592   Derivative/Non-derivative trans. at $32.8 per share. 609,817
06/03/2019 Michael Bell
Chief Financial Officer
6,197   Derivative/Non-derivative trans. at $32.8 per share. 203,261
06/03/2019 Sasha King
Chief Commercial Officer
4,322   Derivative/Non-derivative trans. at $32.8 per share. 141,761
06/03/2019 James P. Yee
Chief Medical Officer
1,239   Derivative/Non-derivative trans. at $32.8 per share. 40,639
05/20/2019 Michael Bell
Chief Financial Officer
2,202   Disposition at $32.1 per share. 70,684
05/20/2019 Michael Bell
Chief Financial Officer
292   Derivative/Non-derivative trans. at $6.31 per share. 1,842
05/20/2019 Michael Bell
Chief Financial Officer
938   Derivative/Non-derivative trans. at $5.9 per share. 5,534
05/20/2019 Michael Bell
Chief Financial Officer
139   Derivative/Non-derivative trans. at $2.8 per share. 389
05/20/2019 Michael Bell
Chief Financial Officer
833   Derivative/Non-derivative trans. at $1 per share. 833
/news/latest/company/us/cdna

MarketWatch News on CDNA

  1. Charting a bull-trend pullback, S&P 500 nails first support (2,873)

    10:28 a.m. June 13, 2019

    - Michael Ashbaugh

  2. CareDx stock price target raised to $46 from $38 at Raymond James

    8:20 a.m. March 22, 2019

    - Tomi Kilgore

  3. Harry Boxer’s four stocks to watch this week

    1:46 p.m. Nov. 1, 2018

    - Harry Boxer

  4. CareDX stock soars nearly 20% after earnings

    6:40 p.m. Aug. 9, 2018

    - Max A. Cherney

  5. CareDx stock price target raised to $10 from $8 at Raymond James

    7:50 a.m. March 23, 2018

    - Tomi Kilgore

  6. Lowe’s Is Adding Three New Directors to Board

    11:15 p.m. Jan. 26, 2018

    - Barron's Online

  7. Activist Starboard Value Squares Up Its Position in Monotype

    11:55 p.m. Oct. 13, 2017

    - Barron's Online

  8. CareDx upgraded to outperform from market perform at Raymond James

    6:58 a.m. Sept. 27, 2017

    - Tomi Kilgore

  9. Almost half of venture-backed IPOs this year are losers

    5:00 a.m. Oct. 3, 2014

    - Philip van Doorn

/news/nonmarketwatch/company/us/cdna

Other News on CDNA

  1. CareDx, Inc 2019 Q3 - Results - Earnings Call Presentation

    11:14 a.m. Nov. 1, 2019

    - Seeking Alpha

  2. CareDx slides 11.9% post Q3 results

    8:45 a.m. Nov. 1, 2019

    - Seeking Alpha

  3. 10-Q: CAREDX, INC.

    4:31 p.m. Oct. 31, 2019

    - Edgar Online - (EDG = 10Q, 10K)

  4. Top Ranked Momentum Stocks to Buy for October 18th

    9:09 a.m. Oct. 18, 2019

    - Zacks.com

  5. CareDx Acquires XynManagement For Pre-Transplant Tech

    3:27 p.m. Sept. 6, 2019

    - Seeking Alpha

  6. Caredx Inc (CDNA) CEO Peter Maag Sold $1.4 million of Shares

    5:16 p.m. Aug. 8, 2019

    - GuruFocus.com

  7. 10-Q: CAREDX, INC.

    3:57 p.m. Aug. 1, 2019

    - Edgar Online - (EDG = 10Q, 10K)

  8. Microcaps mostly among midday movers

    11:45 a.m. July 16, 2019

    - Seeking Alpha

  9. CareDx down 13% on bearish Kerrisdale report

    11:32 a.m. July 16, 2019

    - Seeking Alpha

  10. CareDx, Inc.: Poor Prognosis For Key Transplant Rejection Test

    9:00 a.m. July 16, 2019

    - Seeking Alpha

  11. Loading more headlines...

At a Glance

CareDx, Inc.

3260 Bayshore Boulevard

Brisbane, California 94005

Phone

1 4152872300

Industry

Healthcare Provision

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2019

Revenue

$76.57M

Net Income

$-46.76M

2018 Sales Growth

58.4%

Employees

231.00

/news/pressrelease/company/us/cdna

Press Releases on CDNA

  1. CareDx to Participate in Upcoming Investor Conferences

    7:00 a.m. Nov. 19, 2019

    - GlobeNewswire

  2. CareDx to Participate in Upcoming Investor Conferences

    7:00 a.m. Nov. 19, 2019

    - GlobeNewswire

  3. CareDx at ASN Kidney Week

    7:00 a.m. Nov. 6, 2019

    - GlobeNewswire

  4. CareDx at ASN Kidney Week

    7:00 a.m. Nov. 6, 2019

    - GlobeNewswire

  5. CareDx Advances Patient Care with AlloSure 3.0

    7:00 a.m. Nov. 4, 2019

    - GlobeNewswire

  6. CareDx Advances Patient Care with AlloSure 3.0

    7:00 a.m. Nov. 4, 2019

    - GlobeNewswire

  7. CareDx Reports Third Quarter 2019 Results

    4:24 p.m. Oct. 31, 2019

    - GlobeNewswire

  8. CareDx Reports Third Quarter 2019 Results

    4:05 p.m. Oct. 31, 2019

    - GlobeNewswire

  9. CareDx Adds HistoMap To Testing Portfolio

    8:01 a.m. Sept. 24, 2019

    - GlobeNewswire

  10. CareDx Adds HistoMap To Testing Portfolio

    8:00 a.m. Sept. 24, 2019

    - GlobeNewswire

  11. Loading more headlines...
Link to MarketWatch's Slice.